AzurRx BioPharma Inc. (NASDAQ:AZRX) went down by -7.33% from its latest closing price compared to the recent 1-year high of $2.63. The company’s stock price has collected -6.08% of loss in the last five trading sessions. Press Release reported 15 hours ago that AzurRx BioPharma to Participate in “Fireside Chat” at the H.C. Wainwright Global Life Sciences Conference
Is It Worth Investing in AzurRx BioPharma Inc. (NASDAQ :AZRX) Right Now?
Plus, the 36-month beta value for AZRX is at 1.69.
AZRX currently public float of 29.48M and currently shorts hold a 7.71% ratio of that float. Today, the average trading volume of AZRX was 8.01M shares.
AZRX’s Market Performance
AZRX stocks went down by -6.08% for the week, with a monthly drop of -4.79% and a quarterly performance of 79.47%, while its annual performance rate touched 77.95%. The volatility ratio for the week stands at 11.96% while the volatility levels for the past 30 days are set at 12.38% for AzurRx BioPharma Inc.. The simple moving average for the period of the last 20 days is -15.14% for AZRX stocks with a simple moving average of 45.83% for the last 200 days.
Analysts’ Opinion of AZRX
National Securities, on the other hand, stated in their research note that they expect to see AZRX reach a price target of $9. The rating they have provided for AZRX stocks is “Buy” according to the report published on June 11th, 2019.
Oppenheimer gave a rating of “Outperform” to AZRX, setting the target price at $6 in the report published on October 17th of the previous year.
AZRX Trading at 8.08% from the 50-Day Moving Average
After a stumble in the market that brought AZRX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -47.15% of loss for the given period.
Volatility was left at 12.38%, however, over the last 30 days, the volatility rate increased by 11.96%, as shares surge +1.46% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +70.30% upper at present.
During the last 5 trading sessions, AZRX fell by -6.08%, which changed the moving average for the period of 200-days by +71.18% in comparison to the 20-day moving average, which settled at $1.6390. In addition, AzurRx BioPharma Inc. saw 43.30% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for AZRX
The total capital return value is set at -262.42, while invested capital returns managed to touch -333.90. Equity return is now at value -472.30, with -243.00 for asset returns.
Based on AzurRx BioPharma Inc. (AZRX), the company’s capital structure generated 34.75 points at debt to equity in total, while total debt to capital is 25.79.
The liquidity ratio also appears to be rather interesting for investors as it stands at 0.80.